CASI Pharmaceuticals CASIF
OTC CASIF
$0.10 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

CASI Pharmaceuticals (CASIF) Receivables - Other (2021 - 2025)

Updated

CASI Pharmaceuticals' Receivables - Other came in at $779,000 for Q4 2025, unchanged from $779,000 a year earlier.

Analysis

CASI Pharmaceuticals (CASIF) Receivables - Other (2021 - 2025) Analysis & Trends

Going back to Q4 2021, CASI Pharmaceuticals' Receivables - Other data covers 8 quarters.

  • Receivables - Other carries a four-year compound annual growth rate of 0.0% (FY2021 to FY2025).
  • Going back by year, Receivables - Other was $779,000 in FY2024 (+32.7%), $587,000 in FY2023 (-24.6%), $779,000 in FY2022 (unchanged) and $779,000 in FY2021.
  • The five-year range for quarterly Receivables - Other is $209,000 (Q1 2024) to $1.03 million (Q3 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 CASI Pharmaceuticals 2.06 Mn -18.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 779,000.00
Dec 31, 2024 779,000.00
Sep 30, 2024 1.03 Mn
Jun 30, 2024 963,000.00
Mar 31, 2024 209,000.00
Dec 31, 2023 587,000.00
Dec 31, 2022 779,000.00
Dec 31, 2021 779,000.00
API Access

CASI Pharmaceuticals Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=CASIF&period=max&api_key=YOUR_API_KEY